State department
Ended Awarded Last action
- Contract number
- 75P00220F80066
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Administration
Department of Health and Human Services
- Obligated
- $451,455
Award facts
- Contract value 100% obligated
- $451,455.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Original award | $451,455 |
About this award
The U.S. Department of State's Office of the Assistant Secretary for Administration awarded a firm fixed-price delivery order valued at $451,455 to GlaxoSmithKline, LLC on April 13, 2020, with completion targeted for May 13, 2020. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not contain a set-aside designation. The work will be performed in Research Triangle Park, North Carolina, where GlaxoSmithKline maintains its primary operations as a foreign-owned pharmaceutical company providing medical products and services to federal agencies.
GlaxoSmithKline is a major supplier of pharmaceutical products to the U.S. government, with an extensive portfolio that includes vaccines, antiviral medications, and medical countermeasures distributed across multiple federal agencies. The company holds significant Indefinite Delivery Contracts with the Centers for Disease Control and Prevention, Department of Veterans Affairs, and maintains a Federal Supply Schedule contract with a $3.9 billion ceiling. This particular delivery order represents part of GlaxoSmithKline's ongoing role in supporting federal healthcare and immunization programs, leveraging its established position within the government's pharmaceutical supply chain.
Quick answers
Who was awarded contract 75P00220F80066?
75P00220F80066 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Administration (Department of Health and Human Services) on April 13, 2020.
How much is contract 75P00220F80066 worth?
The government has obligated $451,455 on 75P00220F80066.
Is contract 75P00220F80066 an order under another contract?
Yes. 75P00220F80066 is a delivery order under V797P2298D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75P00220F80066 competed?
The extent of competition for 75P00220F80066 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award